KMC SPECIALITY HOSPITALS (INDIA) LTD. Q1 FY27 Results

KMC Speciality Hospitals (Kauvery Hospital, Trichy) reported standalone Q1 FY27 revenue from operations of ₹91.78 Cr, up 37.9% YoY from ₹66.55 Cr and up 11.6% QoQ from ₹82.25 Cr. Standalone PAT more than doubled YoY to ₹16.57 Cr from ₹7.54 Cr (+119.9%), and rose 13.3% QoQ from ₹14.63 Cr, with EPS at ₹1.02 versus ₹0.46 a year ago and ₹0.90 last quarter. There are no exceptional or one-off items disclosed in either period, so the YoY jump is organic rather than a base-effect artefact.

The profit growth was driven by operating leverage: total expenses rose 24.1% YoY (₹71.15 Cr vs ₹57.35 Cr) while total income rose 39.0% YoY, so operating profit margin (EBITDA/revenue) expanded to 31.0% from 24.7% a year ago, and net profit margin expanded to 17.7% from 11.2%. Employee benefits expense (+27.6% YoY) and other expenses (+28.0% YoY) grew broadly in line with volumes, but finance costs actually declined YoY (₹2.00 Cr vs ₹2.16 Cr) despite the larger revenue base, adding directly to the bottom line. Sequentially margins were roughly flat-to-softer (OPM 31.0% now vs 31.5% in Q4 FY26), so the YoY expansion is the more meaningful signal per our comparison hierarchy.

The stock went into the print at ₹132.9, down 1.9% over the past month of trading.

For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 4 consecutive quarters; revenue is at a 6-quarter high.

There is no formal management guidance on record from our database or the filing, and no analyst/brokerage consensus or Q1 preview could be found for this stock in web search — as a small, single-facility standalone hospital company it does not appear to carry formal sell-side coverage, so both vs-guidance and vs-street are unknown rather than beat/miss. The filing itself carries no MD&A or press-release commentary beyond the standard boilerplate notes (single-segment disclosure, review report details), so there is no management framing to reconcile against the numbers this quarter. Separately, the company disclosed promoter share encumbrances on August 5 and August 12, 2026, just ahead of this result — a shareholding-pattern item unrelated to the operating print but worth flagging as it surfaced in the same week.